期刊
NANO TODAY
卷 6, 期 5, 页码 478-492出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2011.08.002
关键词
Nucleus; Mitochondria; Endoplasmic reticulum; Golgi apparatus; Nanoparticles; Controlled release; Targeted therapy
Over the past decade, research interest in the application of biomedical nanotechnology to the diagnosis and treatment of disease has grown significantly, and physiological barriers to nanoparticle delivery may now be rationally overcome. Subcellular targeting is defined as engineered nanoparticle intracellular interactions, processing, and trafficking, and is a rapidly developing frontier of biomedical innovation. The potential clinical impact of nanoparticle subcellular targeting may be appreciated when considering the promise of effective gene therapies, molecular imaging devices, and treatments for organelle-specific diseases. In this review, we discuss recent innovations in the materials, ligands, and methods employed in designing subcellular nanotechnology, from cellular internalization methods and endosomal escape to recent approaches used to target the nucleus, mitochondria, endoplasmic reticulum, Golgi apparatus, as well as other organelles and intracellular events. (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据